Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

116.59 +1.29 (+1.12%)
Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
40 41 Next >
Is Abbott Laboratories a Buy?
If you're willing to invest with the right mindset, it could be a great option. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Less Is More: Abbott’s Approach to Packaging Innovation
Via ACCESSWIRE
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing
You'll want to hold on to these players for the long term. 
Via The Motley Fool
September Rally? 3 Healthcare Stocks to Buy Before Liftoff.
The anticipated volume of future healthcare spending makes this a time to look at healthcare stocks to buy for the long term. 
Via InvestorPlace
The 3 Best Pharma Stocks to Buy Now: September 2023
There are pharma stocks to buy for each type of investor. This article explores the best options in the industry. 
Via InvestorPlace
Abbott Joins Billion Dollar Roundtable
Via ACCESSWIRE
Looking At Abbott Laboratories's Recent Unusual Options Activity
Via Benzinga
2 Incredible Stocks to Buy on the Dip
Today's bargain may pay off big down the road. 
Via The Motley Fool
Down 10.3%, Is Abbott Laboratories Stock a Buy on the Dip?
Its latest pullback could be an opportunity to buy a legendary dividend stock before it begins a long upward climb. 
Via The Motley Fool
The 3 Most Promising Healthcare Stocks to Own Now
These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products. 
Via InvestorPlace
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Peering Into Abbott Laboratories's Recent Short Interest
Via Benzinga
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
These reliable dividend payers are a fantastic opportunity for investors to generate passive income. 
Via The Motley Fool
A Significant Reversal is in Sight for These 5 Med Tech Companies
Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand. 
Via MarketBeat
This Is What Whales Are Betting On Abbott Laboratories
Via Benzinga
2 Blue Chip Dividend Stocks That Are Top Buys in August
These two dividend-paying healthcare stocks stand out as top buys right now. 
Via The Motley Fool
How Lawmakers Want To Stop Cronobacter Outbreaks That Spurred Baby Formula Shortage Last Year
Under bipartisan Congressional legislation, baby formula manufacturers must notify the U.S. 
Via Benzinga
5 Good Reasons it's Time to Buy High-Yield Dividend King 3M
3M settled the ear plug lawsuit, clearing the path forward. The stock offers investors a high yield and value that may be too hard to pass up 
Via MarketBeat
Topics Lawsuit
Exposures Financial Legal
1 Stock-Split Stock Billionaires Are Buying Hand Over Fist and 1 Unexpected Stock-Split Stock They're Selling
Some of the world's most successful investors are focusing on stocks. 
Via The Motley Fool
U.S. Credit Rating Concerns? Here Are 3 Stocks to Protect Your Portfolio
Looking for stocks to buy amid the U.S. credit rating downgrade? Look no further. These companies have you covered. 
Via InvestorPlace
How Is The Market Feeling About Abbott Laboratories?
Via Benzinga
Is Abbott Laboratories Stock a Buy Now?
The healthcare company recently boosted its guidance. 
Via The Motley Fool
Want Growing Passive Income? This Dividend King Could Be a Smart Buy
The company boasts one of the longest dividend growth streaks in the healthcare sector. 
Via The Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Investors can expect steady returns from these two longtime market-beaters. 
Via The Motley Fool
Down 4% to 17%, These Monster Dividend Stocks Could Be Picking Up Steam
These companies have shown they can increase their lucrative dividends regardless of company struggles in recent times. 
Via The Motley Fool
Trillion-Dollar Trio: These 3 Super Growth Stocks Will Dominate the Market by 2035
As companies naturally continue to expand and the stock market grows, trillion-dollar valuations will be a more common occurrence. 
Via InvestorPlace
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
Via Benzinga
2 Best Healthcare Stocks to Buy Right Now
The healthcare sector has plenty of growth tailwinds. 
Via The Motley Fool
Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval
Boston Scientific Corp (NYSE: BSX) will present results from ADVENT pivotal trial for its Farapulse Pulsed Field Ablation (PFA) system at the 2023 European Society of Cardiology Congress on 27 August.... 
Via Benzinga
Exposures Product Safety
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.